At the moment there is no cure for this disease, but scientists have found out how the disease progresses and how to deal with it in the future.

A high-tech medical device company develops the world's first invisible sensor for people with diabetes.

The presence of SARS-CoV-2-specific memory T cells can facilitate the progression of coronavirus infection.

The first-of-its-kind respiratory syncytial virus vaccine developed by artificial intelligence has shown good results.

The FDA has granted an orphan status to MIV-818 a new hepatocellular carcinoma drug manufactured by a small biotech company.

According to scientists, the new drug is chemically aggressive and it is able to get inside the cells and destroy tuberculosis bacteria.

Experts hope that the simple procedure will become standard for middle-aged people who are at risk of developing such disease.

Colorectal cancer is one of the most common cancer pathologies in both men and women. The risk of developing is 4.2% and 4.5% in women and men, respectively.

The therapy is much better tolerated by cancer patients taking a placebo openly than those from the control group that did not receive any additional tablets.

Scientists have revealed the reduction of the number of cancer polyps due to activity of eicosapentaenoic acid.